Core Scientific, Inc. Tranche 2 Warrants

FRC's fair value estimate for Core Scientific, Inc. Tranche 2 Warrants, and the rating behind it. CORZZ last traded at $17.64; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Valuation, profitability, liquidity and leverage ratios for Core Scientific, Inc. Tranche 2 Warrants. Starting points for Core Scientific, Inc. Tranche 2 Warrants: EPS -$4.41, beta 6.43 — an Software - Infrastructure name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend history, yield and payout sustainability for Core Scientific, Inc. Tranche 2 Warrants. Core Scientific, Inc. Tranche 2 Warrants does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Reported vs. expected earnings history for Core Scientific, Inc. Tranche 2 Warrants. Trailing twelve-month EPS for Core Scientific, Inc. Tranche 2 Warrants stands at -$4.41. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Income statement, balance sheet and cash flow history for Core Scientific, Inc. Tranche 2 Warrants. Core Scientific, Inc. Tranche 2 Warrants has reported as a listed company since 2024. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Core Scientific, Inc. Tranche 2 Warrants valued side by side against its closest peers. Core Scientific, Inc. Tranche 2 Warrants is measured against Software - Infrastructure peers within the Technology sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Which institutions hold Core Scientific, Inc. Tranche 2 Warrants, and how their positions are changing. At a $5.72B market value, institutional positions materially move Core Scientific, Inc. Tranche 2 Warrants's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Buying and selling by Core Scientific, Inc. Tranche 2 Warrants executives and directors. Shares of Core Scientific, Inc. Tranche 2 Warrants have traded between $21.26 and $21.43 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

U.S. Senate disclosures naming Core Scientific, Inc. Tranche 2 Warrants. Core Scientific, Inc. Tranche 2 Warrants is a $5.72B Technology company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

U.S. House of Representatives disclosures naming Core Scientific, Inc. Tranche 2 Warrants. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

Latest headlines and company announcements for Core Scientific, Inc. Tranche 2 Warrants. Coverage tracks Core Scientific, Inc. Tranche 2 Warrants within Software - Infrastructure (Technology). Press releases and market coverage, newest first.